CCL5 and Alzheimer disease: It is well-established that IP-10, RANTES, and TNFα are significantly increased in Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple Sclerosis (MS), HIV-associated dementia and Neuropathic Pain Syndrome96–115.